Cryoport Inc
CYRX5.543USD
-0.036-0.65%
Market hours （ET）Quotes delayed by 15 min
276.67MMarket Cap
LossP/E TTM
More Details of Cryoport Inc Company
Cryoport, Inc. provides supply chain solutions for the Life Sciences with a focus on cell and gene therapies. The Company enables manufacturers, contract manufacturers, contract research organizations, developers, and researchers to carry out their respective business with products and services. It provides a range of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories.
Company Info
Company codeCYRX
Company nameCryoport Inc
IPO dateJul 24, 2015
Founded at1990
CEOMr. Jerrell Wilson (Jerry) Shelton
Number of employees1090
Security typeOrdinary Share
Fiscal year-endJul 24
Address112 Westwood Place, Suite 350
CityBRENTWOOD
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code37027
Phone19492321900
Websitehttps://www.cryoport.com/
Company codeCYRX
IPO dateJul 24, 2015
Founded at1990
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
706.97K
+3.89%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
27.38K
+88.35%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
26.43K
+94.55%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
11.96K
-17.29%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Richard J. Berman
Mr. Richard J. Berman
Lead Independent Director
Lead Independent Director
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
706.97K
+3.89%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
27.38K
+88.35%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
26.43K
+94.55%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
11.96K
-17.29%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
BioLogistics solutions
138.63M
60.70%
Life Science products
74.72M
32.72%
BioStorage/Bioservices
15.03M
6.58%
By RegionUSD
Name
Revenue
Proportion
Americas
126.37M
55.33%
Europe & Middle East & Africa (EMEA)
59.60M
26.09%
Asia Pacific
42.42M
18.57%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
BioLogistics solutions
138.63M
60.70%
Life Science products
74.72M
32.72%
BioStorage/Bioservices
15.03M
6.58%
Shareholder
Update time: Sun, Feb 23
Update time: Sun, Feb 23
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Cadian Capital Management LP
9.83%
Morgan Stanley & Co. LLC
9.20%
Brown Capital Management, LLC
8.89%
Millennium Management LLC
8.26%
BlackRock Institutional Trust Company, N.A.
6.03%
Other
57.80%
Shareholder Statistics
Shareholder
Proportion
Cadian Capital Management LP
9.83%
Morgan Stanley & Co. LLC
9.20%
Brown Capital Management, LLC
8.89%
Millennium Management LLC
8.26%
BlackRock Institutional Trust Company, N.A.
6.03%
Other
57.80%
Type
Shareholder
Proportion
Investment Advisor
34.73%
Investment Advisor/Hedge Fund
27.63%
Hedge Fund
23.30%
Research Firm
10.71%
Individual Investor
2.75%
Pension Fund
2.55%
Sovereign Wealth Fund
0.70%
Private Equity
0.61%
Bank and Trust
0.15%
Institutional Shareholding
Update time: Mon, Mar 3
Update time: Mon, Mar 3
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
394
51.74M
103.20%
-14.27M
2024Q4
407
51.87M
104.93%
-14.28M
2024Q3
422
52.00M
105.24%
-13.61M
2024Q2
423
53.55M
108.72%
-9.95M
2024Q1
437
55.31M
112.51%
-7.56M
2023Q4
468
54.03M
110.37%
-6.18M
2023Q3
482
49.41M
101.04%
-7.52M
2023Q2
492
49.81M
109.19%
-5.40M
2023Q1
500
48.02M
99.15%
-8.43M
2022Q4
513
48.06M
98.07%
-6.28M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Cadian Capital Management LP
4.93M
9.87%
+609.02K
+14.10%
Dec 31, 2024
Morgan Stanley & Co. LLC
4.61M
9.24%
+1.32K
+0.03%
Dec 31, 2024
Brown Capital Management, LLC
4.46M
8.93%
-692.65K
-13.45%
Dec 31, 2024
Millennium Management LLC
4.14M
8.29%
+409.35K
+10.97%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
3.02M
6.06%
-18.57K
-0.61%
Dec 31, 2024
The Vanguard Group, Inc.
2.73M
5.47%
-97.22K
-3.44%
Dec 31, 2024
Fred Alger Management, LLC
2.57M
5.14%
-131.83K
-4.88%
Dec 31, 2024
Natixis Investment Managers SA
1.71M
3.43%
--
--
Dec 31, 2024
DWS Investments UK Limited
1.40M
2.8%
+12.86K
+0.93%
Dec 31, 2024
New York State Common Retirement Fund
1.15M
2.3%
-37.55K
-3.17%
Dec 31, 2024
View more
Related ETFs
Update time: Sun, Apr 6
Update time: Sun, Apr 6
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.4%
Inspire Small/Mid Cap ESG ETF
0.16%
JPMorgan Fundamental Data Science Small Core ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Invesco FTSE RAFI US 1500 Small-Mid ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.4%
Inspire Small/Mid Cap ESG ETF
Proportion0.16%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.03%
Avantis US Small Cap Equity ETF
Proportion0.02%
Invesco FTSE RAFI US 1500 Small-Mid ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data